Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minocycline-induced lupus

D K Farver1

  • 1College of Pharmacy, South Dakota State University, Brookings, USA. dfarver@sunflowr.usd.edu

The Annals of Pharmacotherapy
|October 24, 1997
PubMed
Summary

Minocycline treatment for acne can trigger drug-induced lupus in adolescents. Early recognition of symptoms like joint pain and rash is crucial for prompt diagnosis and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zolpidem for antipsychotic-induced parkinsonism.

The Annals of pharmacotherapy·2001
Same author

Quinine-induced hepatotoxicity.

The Annals of pharmacotherapy·1999
Same author

Delayed neutropenia with ticlopidine.

The Annals of pharmacotherapy·1994
See all related articles

Area of Science:

  • Dermatology
  • Rheumatology
  • Pharmacology

Background:

  • Minocycline is a common antibiotic prescribed for acne vulgaris.
  • Drug-induced lupus erythematosus (DILE) is a rare but serious adverse effect of certain medications.
  • Adolescents represent a unique demographic for evaluating medication side effects.

Observation:

  • A 14-year-old female developed symptoms including myalgias, arthralgias, polyarthritis, and facial flushing 5 months after starting minocycline for acne.
  • Laboratory investigations revealed a positive antinuclear antibody test.
  • Discontinuation of minocycline led to rapid symptom resolution within 7 days.

Findings:

  • This case highlights a potential link between minocycline therapy and the development of DILE in an adolescent patient.
  • The clinical presentation mimicked idiopathic lupus erythematosus but resolved upon drug withdrawal.
  • The latency period of 5 months is consistent with other reported cases of DILE.

Implications:

  • Clinicians should maintain a high index of suspicion for DILE in adolescents presenting with lupus-like symptoms while on minocycline.
  • Early identification and cessation of the offending drug are key to favorable outcomes.
  • This case underscores the importance of monitoring for uncommon adverse drug reactions, even with widely used medications.

Related Experiment Videos